Search results (181)
« Back to NewsProfessor KJ Patel awarded major European Research Council Advanced Grant
23 June 2026
Professor Patel is one of fourteen researchers at the University of Oxford awarded Advanced Grants from the European Research Council (ERC), each worth up to €2.5 million over a period of five years.
New studies shed light on how best to guide heart artery procedures
19 June 2026
Three clinical trials have shed new light on which approaches are most useful when treating narrowed heart arteries. They challenge the current guidance on how to insert stents.
Reversing T cell exhaustion improves effectiveness of myeloma immunotherapies
19 May 2026
Researchers at the Icahn School of Medicine at Mount Sinai, Bristol Myers Squibb (BMS), and the University of Oxford have discovered a way to give worn-out immune cells a second wind in the fight against multiple myeloma.
New AI model predicts how cells choose their fate
12 May 2026
Researchers from the University of Oxford, the Stowers Institute for Medical Research, Helmholtz Munich, and the Technical University of Munich have developed a new artificial intelligence framework that helps uncover how cells make developmental decisions.
Heart scan and blood test improve risk prediction for inherited heart condition, major study finds
11 May 2026
A large international study led by researchers at the University of Oxford and the University of Virginia (USA) has identified a new model for predicting outcomes for hypertrophic cardiomyopathy (HCM) – a heart condition that is the most frequent cause of sudden cardiac death in younger individuals.
Congratulations to our new Associate Professors
7 May 2026
RDM is delighted to announce that the title of Associate Professor has been conferred on four of our researchers. Each of our new Associate Professors has been awarded the title in recognition of their contributions to research, teaching and citizenship at the University and beyond.
Research uncovers new mechanism controlling inflammation in immune cells
29 April 2026
Researchers from the University of Oxford's Radcliffe Department of Medicine and the University of Surrey have discovered that a key immune enzyme controls inflammation in a way that does not depend on its well-known function.
Pramila Rijal awarded grant from Academy of Medical Sciences Springboard Programme
15 April 2026
Now in its 11th year, Springboard supports researchers at a critical point in their careers, when many are establishing laboratories for the first time and need the freedom to explore ambitious questions.
New AI tool can predict heart failure at least five years before it develops
8 April 2026
Programme uses data from routine CT scans to help doctors identify high-risk patients earlier than ever before
Onima Chowdhury receives Cancer Research UK clinical trial grant
8 April 2026
Congratulations to Dr Onima Chowdhury, who has been awarded a clinical trial grant by Cancer Research UK to improve treatment of Myelodysplastic Syndromes.
Announcing new Principal Investigator 2026
7 April 2026
Following RDM’s annual call for researchers to apply for Principal Investigator (PI) status, we are delighted to announce the designation of a new PIs for 2026.
Heavier drinking linked to higher levels of harmful “hidden” fat, study finds
25 March 2026
A study of more than 5,700 adults suggests that higher alcohol consumption is associated with increased levels of visceral fat - the type of fat stored deep inside the abdomen and linked to poorer health outcomes.
Paul Leeson named NIHR Senior Investigator
24 March 2026
Professor Paul Leeson is one of seven academics in the University of Oxford's Medical Sciences Division who have been named National Institute of Health Research (NIHR) Senior Investigators. This award recognises the most prominent and prestigious researchers of applied health and social care.
Oxford University spinout Dark Blue Therapeutics acquired to advance leukaemia treatment
23 March 2026
Oxford University spinout Dark Blue Therapeutics has been acquired by global biotechnology company Amgen in a deal worth up to US$840 million, marking a major milestone for Oxford-led cancer research and innovation. The deal reflects years of collaborative, multidisciplinary work across the University and its partners to translate fundamental research into promising new medicines.
RDM Day 2026: Celebrating scientific excellence and collaboration
18 March 2026
RDM Day, held on Tuesday 17 March at the Mathematical Institute, brought together researchers, professional services staff and students from across the Radcliffe Department of Medicine for a full day of science, networking and community building.
Paresh Vyas receives CRUK Discovery Programme Award
11 March 2026
Congratulations to Professor Paresh Vyas, who has been awarded a Discovery Research grant from Cancer Research UK to investigate cancer immunotherapies.
Congratulations to 2025 RDM Graduate Citizenship Award Winners
12 February 2026
Congratulations to the winners of the 2025 RDM Graduate Citizenship Award; Casey Johnson and Alexander Redmond.
Night-time changes in metabolism may be driving common liver disease
12 January 2026
Researchers at the University of Oxford have discovered that the most common liver disease follows a strong day-night pattern, and the metabolic changes that drive the disease are most pronounced overnight, when the body is least able to process sugar and fat.